Latest News

LaRDR has expanded to New Zealand!

LaRDR has successfully expanded to New Zealand and started patient recruitment for important long-term observational research in lymphoma. Dr Leanne Berkahn is leading Auckland City Hospital to be the first site recruiting patients with us. We welcome participation from more New Zealand hospitals.

We also welcome project proposals from international collaborations, research institutes, clinicians, medical students and other interested parties. Navigate to our Research page for more information.

Contact our project manager to discuss further: 


What is LaRDR?

The Lymphoma and Related Diseases Registry (LaRDR) is an Australasian initiative to improve the treatment and outcomes of patients with lymphoma.

The LaRDR is managed by Monash University’s School of Public Health and Preventive Medicine, through the Transfusion Research Unit, which manages a number of other clinical registries for important blood disorders.

The registry will include all new cases of Hodgkin and non-Hodgkin lymphomas at registered hospital sites.   National representative data on diagnosis and treatment will be collected, allowing the LaRDR team to

  • Understand access to care
  • Monitor trends in practice, outcomes and survival
  • Explore variation in factors that influence outcomes including survival and quality of life
  • Benchmark outcomes nationally and internationally
  • Act as a resource for clinical trials

Estimated number of new cases of Lymphoma diagnosed in Australia in 2019


Estimated number of deaths from Lymphoma in Australia in 2019


Chance of surviving Leukaemia in Australia for at least 5 years (2009-2013)

Source: Australian Institute of Health and Welfare. (2019). Cancer in Australia 2019. Canberra: AIHW.